{"schema_version":"secwatch.filing_event.v1","accession":"0000719135-23-000002","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2023-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.866387+00:00","generated_at":"2026-06-20T17:20:20.255775+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Apyx Medical reports preliminary Q4 revenue $12.1-12.5M (-26-28% YoY); full year $44-44.4M (-8-9%)","bullets":["Advanced Energy rev Q4 $10.1-10.5M (-30-33% YoY); OEM rev $2.0M (+12% YoY).","Full year Advanced Energy $36.4-36.8M (-14-15%); OEM $7.6M (+37%).","CEO cites continued disruption from FDA Medical Device Safety Communication.","Expects 2023 Advanced Energy sales growth >35% YoY; plans to submit 510(k) for new indication by Jan 2023.","Implementing expense cuts to improve cash flow; evaluating options for liquidity enhancement."],"urls":{"canonical":"https://secwatch.observer/filing/0000719135-23-000002","json":"https://secwatch.observer/filing/0000719135-23-000002.json","markdown":"https://secwatch.observer/filing/0000719135-23-000002.md","text":"https://secwatch.observer/filing/0000719135-23-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000002/0000719135-23-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000002/apyx-20230110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:20:20.255775+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27393d4bd04e7fcc2b2b55df1f21bfbb87baa62b","claim":"Apyx Medical Corp reported preliminary financial results for the quarter and year ended December 31, 2022.","evidence_excerpt":"On January 10, 2023, Apyx Medical Corporation (the \"Company\") issued a press release reporting on its preliminary revenue results for the quarter and year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000002/0000719135-23-000002-index.htm","confidence":0.5,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2022"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}